Back to search

Thalidomide as salvage therapy for chronic graft-versus-host disease

Data up to Jan 2025

Published1995
Citations194
References24

Total Citations Per Year

Abstract

References (24)

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

1987 • 540 citations

Thalidomide for the Treatment of Chronic Graft-versus-Host Disease

1992 • 394 citations

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation

1988 • 346 citations

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease

1988 • 289 citations

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease

1993 • 266 citations

Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789]

1987 • 248 citations

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

1989 • 219 citations

Thalidomide Neuropathy Incidence and Clinicoelectrophysiologic Findings in 42 Patients

1994 • 192 citations

Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789]

1987 • 176 citations

WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients.

1971 • 149 citations

Graft-Versus-Host Disease

2008 • 139 citations

Cutaneous Manifestations of Graft‐Versus‐Host Disease

1981 • 122 citations

Hyperfractionated total body irradiation for bone marrow transplantation. results in seventy leukemia patients with allogeneic transplants

1983 • 121 citations

Thalidomide treatment for chronic graft‐versus‐host disease

1991 • 96 citations

Thalidomide Therapy for Inflammatory Dermatoses

1984 • 95 citations

Recognition, incidence, and management of oral graft-versus-host disease.

1990 • 89 citations

Graft-Versus-Host Disease

1990 • 77 citations

A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.

1987 • 76 citations

Thalidomide in leprosy reaction

1994 • 37 citations

The potential use of thalidomide in the therapy of graft-versus-host disease—A review of clinical and laboratory information

1990 • 37 citations

Poor graft function associated with graft-versus-host disease after allogeneic marrow transplantation.

1987 • 33 citations

Therapy of chronic graft-v-host disease in a rat model

1989 • 31 citations

Studies on graft versus host (GvH) reactions. I. Impairment of hemopoietic stroma in mice suffering from GvH disease.

1981 • 26 citations

Hemopoietic progenitor cell function after hla‐identical sibling bone marrow transplantation: Influence of chronic graft‐versus‐host disease

1986 • 20 citations

Cited By (0)

Loading...
Thalidomide as salvage therapy for chronic graft-versus-host disease (1995) – Blood | Metascience Observatory Explorer